English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Cecilia Follin, Department of Endocrinology, Skane University Hospital, Lund, Sweden. Cecilia.follin@med.lu Conclusion 34 years after CRT and chemotherapy, DTI detects hypothalamic dysfunction in ALL survivors The survivors with overweight were presented with worse hypothalamic damage compared to survivors with normal weight. While CP without HT tumour involvement survivors seemed to be unaffected, the present data suggests important hypothalamic dysfunction after CRT in ALL survivors Cecilia Follin, Sigridur Fjalldal, Daniel Svärd, Danielle van Westen, Sanaz Gabery, Åsa Petersen, Jimmy Lätt, Lars Rylander, Eva Marie Erfurth

endocrine abstracts

Hypothalamic dysfunction revealed by magnetic resonance diffusion tensor imaging in childhood leukemia survivors treated with cranial radiotherapy but not in craniopharyngioma survivors